Диссертация (Роль вторичного гиперпаратиреоза в формировании иммунного статуса и коррекция его изменений амлодипином при хронической почечной недостаточности (клинико-экспериментальное исследование)), страница 35

Knoop, G. Navarro Betonico, H.G. Niesters, R. Zietse, W.Weimar // Kidney Int. – 2001. – Vol. 59. – P. 883–892.320.Vaziri, N.D., Effect of uremia on structure and function of immune system/ N.D. Vaziri, M.V. Pahl, A. Crum, K. Norris // J. Ren. Nutr. – 2012.- Vol. 22 (1).– P. 149–156.321.Vestergaard, P. Medical treatment of primary, secondary, and tertiaryhyperparathyroidism. / P. Vestergaard, S.S. Thomsen. // Curr.

Drug. Saf. - 2011.– Vol. 6 (2). – P. 108–113.322.Vilardaga, J.P. Molecular basis of parathyroid hormone receptor signalingand trafficking: A family B GPCR paradigm. / J.P. Vilardaga, G. Romero, P.A.Friedman, T.J. Gardella // Cell. Mol. Life Sci. – 2011. –Vol. 68 (1). – P. 1–13.323.Wahl, P. FGF23 in chronic kidney disease / P.

Wahl, M. Wolf // Adv. Exp.Med. Biol. – 2012. – Vol. 728. – Р. 107-125.324.Wang, H.E. Chronic kidney disease and risk of death from infection. / H.E.Wang, C. Gamboa, D.G. Warnock, P. Muntner // Am. J. Nephrol. – 2011 – Vol.34. - № 4 – P. 330-336.325.Wang, L.L. Mobilization of endogenous bone marrow derived endothelialprogenitor cells and therapeutic potential of parathyroid hormone after ischemicstroke in mice. / L.L. Wang, D.

Chen, J. Lee, X. Gu, G. Alaaeddine, J. Li, L. Wei,S.P. Yu // PLoS One. – 2014. – Vol. 9 - e87284.326.Wang, J.C. Primary hyperparathyroidism and chronic lymphocyticleukemia. / J.C. Wang, W. Steier, M.K. Aung, M.S. Tobin // Cancer. – 1978. –Vol. 42 (4). – P. 1964–1969.327.Ward, R.A. Methylglyoxal: A stimulus to neutrophil oxygen radicalproduction in chronic renal failure? / R.A. Ward, K.R. McLeish // Nephrol. Dial.Transplant. – 2004. – Vol.

19. – Р. 1702-1707.209328.Warnock, A. Amlodipine prevents apoptotic cell death by correction ofelevated intracellular calcium in a primary neuronal model of Batten disease(CLN3 disease). / A. Warnock, L. Tan, C. Li, K. An Haack, S.B. Narayan, M.J.Bennett // Biochem. Biophys. Res. Commun. – 2013. – Vol.

436 (4). P. 645-649.– doi: 10.1016/j.bbrc.2013.04.113.329.Williams, M.E. Chronic kidney disease/bone and mineral metabolism: theimperfect storm. / M.E. Williams // Semin. Nephrol. – 2009. – Vol. 29, № 2. – P.97–104.330.Wollenweber, T. Myocardial perfusion imaging is feasible for infarct sizequantification in mice using a clinical single-photon emission computedtomography system equipped with pinhole collimators. / T. Wollenweber, C.Zach, C.

Rischpler, R. Fischer, S. Nowak, S.G. Nekolla, M. Gröbner, C. Ubleis,G. Assmann, J. Müller-Höcker [et al.] // Mol. Imaging. Biol. – 2010. – Vol. 12. –P. 427–434.331.Wu, C-C. Calcitriol treatment attenuates inflammation and oxidative stressin hemodialysis patients with secondary hyperparathyroidism. / C-C. Wu, J-H.Chang, C-C. Chen [et al.] / Tohoku Journal of Experimental Medicine. – 2011.

–Vol. 223 (3). – P. 153–159.332.Wu, C-C. Role of T cells in type 2 diabetic nephropathy. / C-C. Wu, H-K.Sytwu, K-C. Lu, Y-F. Lin // Experimental Diabetes Research. – 2011. – Vol.2011. - 9 pages. 514738.333.Yadav, A.K. CD4+CD28null cells are expanded and exhibit a cytolyticprofile in end-stage renal disease patients on peritoneal dialysis. / A.K. Yadav, V.Jha.

// Nephrol. Dial. Transplant. – 2011. – Vol. 26. – P. 1689–1694.334.Yamamoto, I. Circulating bovine lymphocytes contain receptors forparathyroid hormone. / I. Yamamoto, J.T. Potts, Jr., G.V. Segre. // Journal ofClinical Investigation. – 1983. – Vol. 71 (2). – P. 404–407.335.Yamashita, T. Identification of a novel fibroblast growth factor, FGF-23,preferentially expressed in the ventrolateral thalamic nucleus of the brain. / T.Yamashita, M. Yoshioka, N. Itoh // Biochem.

Biophys. Res. Commun. – 2000. –210Vol. 277, № 2. – P. 494–498.336.Yang, D. Contributions of parathyroid hormone (PTH)/PTH-related peptidereceptor signaling pathways to the anabolic effect of PTH on bone. / D. Yang, R.Singh, P. Divieti, J. Guo, M.L. Bouxsein, F.R. Bringhurst. // Bone. - 2007. – Vol.40 (6). – P. 1453-1461.337.Yang, H. Models of chronic kidney disease / H. Yang, Y.

Zuo, А.B. Fogo //Drug Discov Today Dis Models. – 2010. – Vol. 7, №1-2. – Р. 13-19.338.Yang, D. Parathyroid hormone activates PKC-delta and regulatesosteoblastic differentiation via a PLC-independent pathway. / D. Yang, J. Guo, P.Divieti, F.R. Bringhurst // Bone. – 2006. – Vol. 38. – P. 485–496.339.Yeung, C.K. Effects of chronic kidney disease and uremia on hepatic drugmetabolism and transport. / C.K. Yeung, D.D.

Shen, K.E. Thummel, J.Himmelfarb. // Kidney Int. – 2014. – Vol. 85 (3). – P. 522-528.340.Yilmaz, M.E. Are polysulfone dialyzers stimulating cytokines inhemodialyzed patients with hepatitis C ? / M.E. Yilmaz, I.H. Kara, Y. Sari // Dial.Transplant. – 2001. – Vol. 30. – P. 288 – 297.341.Yilmaz, M.I. Comparison of calcium acetate and sevelamer on vascularfunction and fibroblast growth factor 23 in CKD patients: a randomized clinicaltrial. / M.I. Yilmaz, A. Sonmez, M. Saglam [et al.] // Am.

J. Kidney Dis. – 2012.– Vol. 59 (2). – P. 177–185.342.Yoon, J. Naive and Central Memory T-cell lymphopenia in end-stage renaldisease / J. Yoon, S. Gollapudi, M. Pahl [et al.] // Kidney Int. – 2006. – Vol. 70.– Р. 371-376.343.Yoshii,T. Regressionofatherosclerosisby amlodipine viaanti-inflammatory and anti-oxidative stress actions. / T. Yoshii, M.

Iwai, Z. Li, R.Chen, A. Ide, S. Fukunaga, A. Oshita, M. Mogi, J. Higaki, M. Horiuchi //Hypertens. Res. – 2006. – Vol. 29 (6). – P.:457-466.344.Zahran, N. Neutrophil apoptosis: impact of granulocyte macrophage colonystimulating factor on cell survival and viability in chronic kidney disease andhemodialysis patients. / N. Zahran, A. Sayed, I. William, O. Mahmoud, O. Sabry,211M. Rafaat // Arch. Med. Sci. – 2013. – Vol. 9 (6). – P/ 984-989.345.Zaruba, M.M. Parathyroid hormone treatment after myocardial infarctionpromotes cardiac repair by enhanced neovascularization and cell survival. / M.M.Zaruba, B.C. Huber, S. Brunner, E. Deindl, R. David, R.

Fischer, G. Assmann, N.Herbach, S. Grundmann, R. Wanke [et al.] // Cardiovasc. Res. – 2008. – Vol. 77.– P. 722–731.346.Zhang, X. Amlodipine and atorvastatin exert protective and additive effectsvia antiapoptotic and antiautophagic mechanisms after transient middle cerebralartery occlusion in Zucker metabolic syndrome rats. / X.

Zhang, S. Deguchi, K.Deguchi, Y. Ohta, T. Yamashita, J. Shang, F. Tian, N Liu, W. Liu, Y. Ikeda, T.Matsuura, K. Abe. // J. Neurosci. Res. – 2011. – Vol. 89 (8). – P. 1228-1234. doi: 10.1002/jnr.22633.347.Zhang, J. Regulatory T cells/T-helper cell 17 functional imbalance inuraemic patients on maintenance haemodialysis: a pivotal link betweenmicroinflammation and adverse cardiovascular events. / J. Zhang, G.

Hua, X.Zhang, R. Tong, X. Du, Z. Li. // Nephrology. – 2010. – Vol. 15 (1). – P. 33–41.348.Zhang, L. CpG array analysis of histone H3 lysine 4 trimethylation inperipheral blood mononuclear cells of uremia patients. / L. Zhang, Y. Dai, L.Wang, W. Peng, Y. Zhang, Y. Ou [et al.] // DNA Cell. Biol. – 2011. - Vol. 30(3). – P. 179–186.349.Zhou, X.R.

Protective effect of amlodipine on the cytotoxicity induced bycontrast media in human kidney cells / X.R. Zhou, S.B. Duan, Y.M. Peng,F.Y. Liu, Y. Ye, R.H. Liu, G.Y. Li // Zhong Nan Da Xue Xue Bao Yi Xue Ban. –2007. – Vol. 32 (5). – P. 806-811.350.Zou, M.S. 1,25-Dihydroxyvitamin D3 decreases adriamycin-inducedpodocyte apoptosis and loss. / M.S. Zou, J.

Yu, G.M. Nie [et al.] // Int. J. Med.Sci. – 2010. – Vol. 7, № 5. – P. 290–299.351.Zukowska-Szczechowska, E. The effect of hemodialysis with frequent useof cuprophan and polysulfone membranes on activation of complement inpatients with chronic renal failure / E. Zukowska-Szczechowska, D. Moczulski,212W. Grzeszczak [et al.] // Pol. Arch. Med. Wewn. – 1996. – Vol. 96, № 5. – P.458-468..